
BEAM vs DNA
$BEAM vs $DNA head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
BEAM vs DNA: the quick read
- ·BEAM is the larger company by market cap ($2.68B vs $671M).
- ·DNA has been more active on our scanner (239 vs 137 alerts in 30 days).
- ·DNA has the smaller float (65.6M vs 103.5M), which tends to mean sharper, more volatile moves.
- ·Both are biological products, (no diagnostic substances) names, so this is a like-for-like comparison and sector news tends to move them together.
- ·Both stay busy on our scanner, 239 and 137 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·BEAM pays a dividend and DNA does not, which usually means one is being held for income and the other for the move.
- ·They are pulling apart today: DNA is outperforming the other by roughly 10.0 percentage points on the session.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing BEAM and DNA on TheDesperateTrader.
- Is BEAM or DNA the better stock?
- "Better" depends on your goal, and these two are not alike. BEAM is the larger company by market cap ($2.68B vs $671M). DNA has been more active on our scanner (239 vs 137 alerts in 30 days). DNA has the smaller float (65.6M vs 103.5M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between BEAM and DNA?
- The differences that matter: BEAM is roughly 4x the size of the other by market cap ($2.68B vs $671M); they trade at very different share prices ($26.32 vs $11.13); BEAM sits at 34% of its 52-week range against 45% for DNA; only BEAM pays a dividend; our scanner flagged BEAM 137 times in the last 30 days against 239 for DNA. Everything above is measured from the latest completed session and SEC filings.
- Which of BEAM and DNA is more active right now?
- Right now BEAM is at about 1.7x its normal volume and DNA is at about 0.7x, so BEAM is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading BEAM or DNA? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore BEAM and DNA comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.